1. Home
  2. WTFC vs HALO Comparison

WTFC vs HALO Comparison

Compare WTFC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$143.12

Market Cap

9.5B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.77

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTFC
HALO
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTFC
HALO
Price
$143.12
$68.77
Analyst Decision
Strong Buy
Buy
Analyst Count
12
12
Target Price
$154.67
$73.33
AVG Volume (30 Days)
490.0K
2.3M
Earning Date
01-20-2026
11-03-2025
Dividend Yield
1.39%
N/A
EPS Growth
13.95
56.68
EPS
10.89
4.74
Revenue
$2,563,182,000.00
$1,242,852,000.00
Revenue This Year
$17.85
$34.83
Revenue Next Year
$5.85
$24.84
P/E Ratio
$13.20
$14.44
Revenue Growth
13.69
31.19
52 Week Low
$89.10
$46.76
52 Week High
$144.70
$79.50

Technical Indicators

Market Signals
Indicator
WTFC
HALO
Relative Strength Index (RSI) 64.99 58.75
Support Level $142.44 $61.23
Resistance Level $144.70 $69.28
Average True Range (ATR) 2.36 1.69
MACD 0.09 0.69
Stochastic Oscillator 83.60 93.54

Price Performance

Historical Comparison
WTFC
HALO

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: